Skip to main content
Premium Trial:

Request an Annual Quote

BioImagene Buys TissueInformatics from Icoria for Undisclosed Sum

NEW YORK, June 15 (GenomeWeb News) - BioImagene today said it has acquired TissueInformatics from Clinical Data's Icoria business unit for an undisclosed amount.


The Pittsburgh-based tissue image-analysis company develops and applies automated pathology software to enable researchers to quantitatively analyze tissue changes in drug discovery, disease assessment, toxicology, and tissue engineering research.


BioImagene, based in Cupertino, Calif., said the acquisition will boost its presence on the East Coast; expand its footprint in the tox-path area market; and help meet a demand for integrated tissue image-analysis and data- and image-management and -mining products.


BioImagene said it plans to "rapidly" integrate TissueInformatics' core technology into its platform and application suite.


TissueInformatics' management team will help plant BioImagene's presence on the East coast and will maintain its facilities in Pittsburgh, the company said.


Clinical Data acquired Icoria last year for around $12.5 million. In 2004 Icoria changed its name from Paradigm Genetics  after its acquisition of TissueInformatics earlier that year enabled it to change the focus of its business from plant genomics to systems biology and healthcare.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.